A minha Urticária Colinérgica só aparece no inverno — Por quê?

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

A minha Urticária Colinérgica só aparece no inverno — Por quê?

Clinical Summary and Overview

To clearly understand the clinical aspects involved in Urticária Colinérgica This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "A minha Urticária Colinérgica só aparece no inverno — Por quê?" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

A minha Urticária Colinérgica só aparece no inverno — Por quê?

Entendendo a Urticária Colinérgica e a Relação com o Inverno

Uma dúvida frequente nos consultórios de alergologia diz respeito ao surgimento ou à piora de quadros dermatológicos em determinadas épocas do ano, como o relato de pacientes que observam manifestações de urticária colinérgica exclusivamente durante o inverno. Para compreender esse fenômeno, é fundamental analisar a classificação médica das urticárias crônicas, que englobam diferentes subtipos, desde as formas espontâneas até aquelas desencadeadas por estímulos físicos específicos.

As urticárias induzidas compreendem um grupo no qual os sintomas aparecem em resposta a fatores externos determinados. Entre os diversos tipos existentes, destacam-se as reações provocadas por:

  • Variações térmicas, como o frio ou o calor;
  • Estímulos mecânicos, a exemplo do tato, da pressão e da vibração;
  • Exposição aos raios solares;
  • Outros agentes físicos e não físicos.

Quando um paciente relata que os sintomas cutâneos se manifestam estritamente nos meses mais frios, é provável que estejamos diante de uma urticária induzida pelo frio. A queda acentuada na temperatura ambiental atua como o gatilho que desencadeia a liberação de mediadores inflamatórios na pele, resultando nas lesões características. É importante não confundir essa resposta específica com a urticária colinérgica clássica, que costuma ser atrelada ao aumento da temperatura corporal — seja por esforço físico, banhos quentes ou estresse emocional —, embora ambas pertençam ao amplo grupo das urticárias induzidas.

O manejo clínico dessas condições envolve o uso de estratégias preventivas para garantir qualidade de vida ao paciente. O emprego regular de anti-histamínicos sob orientação médica costuma ser uma abordagem eficaz na prevenção das crises. Em casos específicos e mais desafiadores, estudos e pesquisas científicas têm avaliado o papel de terapias avançadas, como o uso de anticorpos monoclonais, embora a indicação exata dependa de uma avaliação minuciosa por parte do médico especialista.

Vale ressaltar que este conteúdo possui caráter estritamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e o plano de tratamento individualizado estabelecido por um médico alergista ou imunologista.

Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema

In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.

💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management

Mast Cell Activation, Histamine, and the Bradykinin Pathway

Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.

Therapeutic Escalation without Overuse of Corticosteroids

As diretrizes internacionais preconizam os anti-histamínicos H1 de segunda geração (não sedativos) em doses otimizadas sob supervisão médica como primeira linha, reservando anticorpos monoclonais anti-IgE (como o omalizumabe) para casos crônicos refratários e evitando ciclos repetidos de corticoides sistêmicos que causam efeito rebote. A investigação com allergy test e avaliação especializada de pele permite excluir gatilhos ocultos e alinhar, quando há atopia coexistente, estratégias como a allergy vaccine.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. For peaceful skin, free from constant itching and sleepless nights due to flare-ups.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Urticária Colinérgica This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... rhinitis treatment When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: